New York State Common Retirement Fund’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,282
Closed -$19.3K 3304
2025
Q1
$19.3K Hold
14,282
﹤0.01% 2984
2024
Q4
$188K Hold
14,282
﹤0.01% 2323
2024
Q3
$160K Sell
14,282
-8,000
-36% -$100K ﹤0.01% 2400
2024
Q2
$240K Sell
22,282
-37,388
-63% -$482K ﹤0.01% 2349
2024
Q1
$889K Buy
59,670
+3,922
+7% +$64.7K ﹤0.01% 1828
2023
Q4
$1.01M Buy
55,748
+5,173
+10% +$78.7K ﹤0.01% 1791
2023
Q3
$877K Buy
50,575
+1,725
+4% +$29.9K ﹤0.01% 1813
2023
Q2
$885K Buy
48,850
+26,350
+117% +$624K ﹤0.01% 1834
2023
Q1
$599K Buy
22,500
+2,150
+11% +$61.2K ﹤0.01% 2091
2022
Q4
$393K Buy
20,350
+850
+4% +$17.8K ﹤0.01% 2435
2022
Q3
$407K Sell
19,500
-8,113
-29% -$155K ﹤0.01% 2438
2022
Q2
$221K Sell
27,613
-16,158
-37% -$103K ﹤0.01% 2755
2022
Q1
$307K Buy
43,771
+12,622
+41% +$129K ﹤0.01% 2637
2021
Q4
$421K Buy
31,149
+14,796
+90% +$235K ﹤0.01% 2522
2021
Q3
$276K Sell
16,353
-5,338
-25% -$113K ﹤0.01% 2765
2021
Q2
$632K Buy
21,691
+2,991
+16% +$93.1K ﹤0.01% 2474
2021
Q1
$735K Buy
18,700
+9,200
+97% +$299K ﹤0.01% 2267
2020
Q4
$216K Buy
9,500
+7,100
+296% +$178K ﹤0.01% 2728
2020
Q3
$54K Buy
+2,400
New +$60K ﹤0.01% 3123

Other funds holding PLRX

New York State Common Retirement Fund's PLRX Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 14,282 shares — an estimated $19.3K sold.

New York State Common Retirement Fund first reported a position in PLRX in Q3 2020 and held it in 19 quarters. The position peaked at $1.01M in Q4 2023. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 14,282 Pliant Therapeutics shares in Q2 2025, an estimated $19.3K.
  • New York State Common Retirement Fund first reported a position in Pliant Therapeutics in Q3 2020 and held it in 19 quarters.
  • New York State Common Retirement Fund's Pliant Therapeutics position peaked at $1.01M in Q4 2023.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.